Diligence memo · auto-generated · as of July 2, 2026
Kantum Diagnostics, Inc.
Kantum Diagnostics, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Kantum Diagnostics, Inc. operates in Medical Devices, based in CONCORD.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Kantum Diagnostics, Inc. has raised $5.3M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.5M on 2021-06-30.
Most recent recorded round closed around 2021-06-30.
Valuation (modeled)modeled
Provath models Kantum Diagnostics, Inc. at approximately $66M (range $2.9M–$394M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.57× the median modeled value of Seed Medical Devices companies in 2019–2021 (23 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 19 months.
Last raise 5.0 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 4.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 69% of Medical Devices peers (233 compared).
Modeled value ranks above 81% of those peers.
Closest niche peers: Gradian Diagnostics Inc, Regent Surgical Health Intermediate Holdings, Inc., Caliber Imaging & Diagnostics, Inc., Dxterity Diagnostics Inc, Sure Count Surgical, LLC.
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.